EUDA Health Holdings Limited

NasdaqCM:EUDA Stock Report

Market Cap: US$45.6m

EUDA Health Holdings Past Earnings Performance

Past criteria checks 0/6

EUDA Health Holdings's earnings have been declining at an average annual rate of -1425.9%, while the Healthcare industry saw earnings growing at 5.5% annually. Revenues have been declining at an average rate of 28% per year.

Key information

-1,425.9%

Earnings growth rate

15.1%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate-28.0%
Return on equityn/a
Net Margin-420.6%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How EUDA Health Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:EUDA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 238-32100
31 Mar 239-28100
31 Dec 2210-2590
30 Sep 2210-360
30 Jun 2210-260
31 Mar 2211-150
31 Dec 2111150
31 Dec 209050

Quality Earnings: EUDA is currently unprofitable.

Growing Profit Margin: EUDA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if EUDA's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare EUDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EUDA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8%).


Return on Equity

High ROE: EUDA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.